A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : p-mTOR

Search Conditions:
Search Keyword : p-mTOR
Search Method : Exact match.
Research Area:

Abbreviation: p-mTOR
Appearance Frequency: 209 time(s)
Long forms: 12

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
phosphorylated mammalian target of rapamycin
(96 times)
(27 times)
p-AKT (32 times)
PI3K (10 times)
LC3 (8 times)
2008 Nephrotic range proteinuria: rare manifestation of scleroderma renal crisis.
phosphorylated mTOR
(74 times)
(18 times)
mTOR (58 times)
p-Akt (18 times)
PI3K (9 times)
2009 Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
(25 times)
(5 times)
mTOR (16 times)
p-Akt (6 times)
PI3K (5 times)
2010 Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats.
phosphorylation of mTOR
(6 times)
(3 times)
mTOR (6 times)
A1ARs (1 time)
CCH (1 time)
2011 Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
(p-PKCzeta/lamda) and mTOR
(1 time)
(1 time)
CR (1 time)
GH (1 time)
IR (1 time)
2014 Growth hormone abolishes beneficial effects of calorie restriction in long-lived Ames dwarf mice.
(1 time)
Complementary Therapies
(1 time)
GD (1 time)
JC (1 time)
mTOR (1 time)
2015 [Effect of Jiakangning Capsule on Thyroid Function and Akt/mTOR Signal Pathway of Graves' Disease Mice: an Experimental Study].
(1 time)
Breast Neoplasms
(1 time)
BC (1 time)
ER (1 time)
pAKT (1 time)
2019 pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation.
phosphorylation state of hepatic mTOR
(1 time)
(1 time)
aa (1 time)
AMPK (1 time)
BCAA (1 time)
2009 mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat.
present study is to investigate the expression of activated mTOR
(1 time)
(1 time)
DFS (1 time)
mTOR (1 time)
OS (1 time)
2010 Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer.
10  prevalence of mammalian target of rapamycin phosphorylation
(1 time)
(1 time)
VEGF (1 time)
2012 Prevalence and clinical significance of mammalian target of rapamycin phosphorylation (p-mTOR) and vascular endothelial growth factor (VEGF) in clear cell carcinoma of the ovary.
11  prognostic value of activated mTOR
(1 time)
(1 time)
BTA (1 time)
mTOR (1 time)
2007 Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma.
12  proportion of OSCC tissues with activated mTOR
(1 time)
(1 time)
mTOR (1 time)
OSCC (1 time)
2008 mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?